Category: Cancer/Oncology
Donor Determined to Shine Light on Cancers of the Hepatobiliary System Gives Second Donation of $10K to The Bili Project Foundation
Funds will go toward the American Society of Clinical Oncologists Young Investigator Award
3-D Mammography Improves Cancer Detection in Dense Breasts
QCCA Evolves to Become the First National Clinically Integrated Network in Oncology
A Network of 19 Independent Practices Across 17 States
Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants, New Webinar Hosted by Xtalks
Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.
Researchers Find a Pathway That Leads to Resistance of Aggressive Brain Tumor Treatment
Dartmouth scientists found a therapeutic approach that should prevent the development of resistance to targeted anti-tumor drugs in gliomas
Two Women Scientists Granted $400k for Promising Lung Cancer Research
Funding supports search for new treatments for the deadliest form of cancer
CytoTest Boosts Global Sales Team
CytoTest announces a significant expansion of its sales team.
CureOne Recognized by Medicare as a Leader in Quality Data Collection and Reporting
QCDR Status Cements Organization's Dedication to Upholding Clinical Standards
MutantDx Liquid Biopsy Detects Cancer Long Before Symptoms Develop
Cancer DNA mutations can now be detected in the blood in femtogram concentrations (one femtogram = one thousand trillionth of a gram)
Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes
In this study of 5,000 women, more women who received Paclitaxel once a week were likely to be alive and free of breast cancer five years after being diagnosed compared to women who received Paclitaxel every three weeks OR women who received Docetaxel (either weekly or every three weeks).
As the Market Prepares for New Regulations Closed System Drug Transfer Set to Grow at CAGR of 10.6 Percent to 2024
Long-awaited Requirements Will Drive Adoption Rates in Key Markets According to Greystone Research Associates
Highlands Oncology Group Professional Achieves Certification in Healthcare Compliance
Amber Kandur, of Highlands Oncology Group, Completed Certification Program in Healthcare Compliance
New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom
Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence.
Cancer Treatment Group Recognized for Their Support of the Symphony of Northwest Arkansas
Highlands Oncology Group Recognized With Corporate Sponsorship Award
Highlands Oncology Group Physician Voted Best of Best by Readers' Poll
Dr. Hershey Garner, of Highlands Oncology Group, Voted Best Oncologist in Northwest Arkansas By Readers' Poll
Definiens Strengthens Position as Global Service Provider in Biopharma
Jacques Corriveau joining as General Manager North America